Bone Biologics Corp (BBLG) News

Bone Biologics Corp (BBLG): $1.12

-0.03 (-2.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BBLG News Items

BBLG News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest BBLG News From Around the Web

Below are the latest news stories about BONE BIOLOGICS CORP that investors may wish to consider to help them evaluate BBLG as an investment opportunity.

BBLG: Bone Biologics Set up For Success

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Although the stock (NASDAQ:BBLG) of Bone Biologics has suffered along with the rest of the biotech-related space, we remain confident in the company’s technology to improve the bone regeneration process, potentially providing relief to millions of back pain sufferers in the US and around the world. The NELL-1 protein and the way

Yahoo | June 7, 2022

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

BURLINGTON, Mass., March 23, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, has been invited to present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30, 2022. A pre-recorded presentation will be available for 72 hours beginning Monday, March 28th at 9:00 a.m. Eastern time. Interested p

Yahoo | March 23, 2022

We're Hopeful That Bone Biologics (NASDAQ:BBLG) Will Use Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | March 18, 2022

BBLG: Bone Biologics Inks Important Supply Agreement

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT In prior research reports we have expressed the importance we believed the partnership with the Musculoskeletal Transplant Foundation (MTF) was to Bone Biologics (NASDAQ:BBLG). Bone has been partnering with the Musculoskeletal Transplant Foundation (MTF), who has been an investor in Bone Biologics for several years. As a

Yahoo | March 18, 2022

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

BURLINGTON, Mass., March 07, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM). MTF Biologics is a global nonprofit organization that provides one of the orthopedic industry’s largest portfolios of allograft tissue.

Yahoo | March 7, 2022

BBLG: Back Pain Solution Potentially on the Way

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT There have been several reports out lately addressing the future of bone regeneration and the technologies surrounding it. We have read these reports and are excited about the market opportunity potential and the growth that has been predicted by industry insiders of between 4.5-5.5% annually. Of course, that’s an estimate and

Yahoo | February 24, 2022

BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today

Today’s price action across the broader market is certainly intriguing to watch. Various large cap stocks are getting hit hard as investors ponder the impacts of what could be as many as four interest rate hikes this year. Now, what was an ultra-bullish market has turned into one where investors are seeking shelter. However, certain niche stocks like Bone Biologics (NASDAQ:BBLG) are surging today. Currently, BBLG stock is up more than 50% at the time of writing on impressive volume. Source: Shut

Yahoo | January 10, 2022

Why Are Bone Biologics Shares Surging On Monday?

Newly listed Bone Biologics Corporation (NASDAQ: BBLG) shares are surging after the Company announced to present at the H.C. Wainwright BioConnect Virtual Conference. Bone Biologics is focused on regenerative medicine for bone. The Company is working on the Nell-1 protein, a bone graft substitute product on bone regeneration in spinal fusion, and has rights to trauma and osteoporosis applications. Recombinant NELL-1 is purified and mixed with 510-K-cleared Demineralized Bone Matrix putty in the

Yahoo | January 10, 2022

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

BURLINGTON, Mass., January 05, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 – 13, 2022. A pre-recorded presentation will be available beginning Monday, January 10 at 7:00 a.m. Eastern time. Interested parties may access a webcast of the presentation on

Yahoo | January 5, 2022

25 Stocks Moving in Wednesday's Pre-Market Session

Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10 million buyback program. Rockwell Medical, Inc. (NASDAQ: RMTI) rose 58.6% to $0.7632 in pre-market trading after the company announced results from a study demonstrated no drug-drug interaction between ferric pyrophosphate citrate and unfractionated heparin. SPI Energy Co., Ltd. (NASDAQ: SPI) shares rose 20% to $7.38 in pre-mark

Yahoo | November 17, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4433 seconds.